However, anti-PTX3 antibodies were more prevalent in patients with SLE than in patients with other autoimmune rheumatic diseases, which suggests that these antibodies protect SLE patients from kidney involvement [17]. This evidence concerns the gene PTX3 and systemic lupus erythematosus.